GSEA by c2wikipathway showed that CXCR2P1 was significantly enriched in Cancer Immunotherapy By PD-1 Blockade (p = 2.676 x 10-4, shown as Figure 5C). This evidence concerns the gene CXCR2P1 and cancer.